AVITA Medical ®, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company, today announced that it will report its first quarter 2026 financial results after the close of the U.S.

Cohealyx® multi-center study interim analysis and new case data to be presentedRECELL® and PermeaDerm® data reinforce a comprehensive approach to ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

VALENCIA, Calif., April 07, 2026 (GLOBE NEWSWIRE)-- AVITA Medical®, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company, today announced its presence at the 2026 American ...

The first time the placebo effect really got under my skin was when I read that roughly one-third of people with irritable ...

Tehran's hardline rhetoric belies a brutal reality facing the regime and Iranian citizens: its economy, vulnerable even ...

Dayton police responded to reports that at least one person with a gunshot wound showed up at Miami Valley Hospital at ...

ALTON - OSF St. Anthony’s Wound Care Center of Excellence has been awarded the prestigious Center of Distinction award by ...

Eluciderm, Inc., a clinical-stage pharmaceutical company developing small molecule therapeutics to promote healing and regenerative repair of injured tissue, announced today that it received the Wound ...